Luveltamab tazevibulin (STRO-002), an anti-folate receptor alpha (FolR) antibody drug conjugate (ADC), demonstrates clinical activity in recurrent/progressive epithelial endometrial cancer (EEC): STRO-002-GM1 phase I dose expansion
Luveltamab Tazevibulin;STRO-002
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Luveltamab tazevibulin (STRO-002), an anti-folate receptor alpha (FolR) antibody drug conjugate (ADC), demonstrates clinical activity in recurrent/progressive epithelial endometrial cancer (EEC): STRO-002-GM1 phase I dose expansion ### Output: Luveltamab Tazevibulin;STRO-002